Stefańska, K.; Ożegowska, K.; Hutchings, G.; Popis, M.; Moncrieff, L.; Dompe, C.; Janowicz, K.; Pieńkowski, W.; Gutaj, P.; Shibli, J.A.;
et al. Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials. J. Clin. Med. 2020, 9, 1102.
https://doi.org/10.3390/jcm9041102
AMA Style
Stefańska K, Ożegowska K, Hutchings G, Popis M, Moncrieff L, Dompe C, Janowicz K, Pieńkowski W, Gutaj P, Shibli JA,
et al. Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials. Journal of Clinical Medicine. 2020; 9(4):1102.
https://doi.org/10.3390/jcm9041102
Chicago/Turabian Style
Stefańska, Katarzyna, Katarzyna Ożegowska, Greg Hutchings, Małgorzata Popis, Lisa Moncrieff, Claudia Dompe, Krzysztof Janowicz, Wojciech Pieńkowski, Paweł Gutaj, Jamil A. Shibli,
and et al. 2020. "Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials" Journal of Clinical Medicine 9, no. 4: 1102.
https://doi.org/10.3390/jcm9041102
APA Style
Stefańska, K., Ożegowska, K., Hutchings, G., Popis, M., Moncrieff, L., Dompe, C., Janowicz, K., Pieńkowski, W., Gutaj, P., Shibli, J. A., Prado, W. M., Piotrowska-Kempisty, H., Mozdziak, P., Bruska, M., Zabel, M., Kempisty, B., & Nowicki, M.
(2020). Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials. Journal of Clinical Medicine, 9(4), 1102.
https://doi.org/10.3390/jcm9041102